Evaluating noncancer effects of trichloroethylene: Dosimetry, mode of action, and risk assessment

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 323-334

  Barton, Hugh A ^a,c   Clewell III, Harvey J ^b  

^a ICF Consulting   (United States)

^b ICF Consulting   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Benchmark dose; Chloral; Developmental toxicity; Dose response assessment; Kidney toxicity; Liver toxicity; Neurotoxicity; PBPK modeling; Trichloroacetate; Trichloroethylene

Indexed keywords

CYSTEINE DERIVATIVE; DICHLOROACETIC ACID; TRICHLOROACETIC ACID; TRICHLOROETHANOL; TRICHLOROETHYLENE; VINYL DERIVATIVE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; EVALUATION; EYE MALFORMATION; FEMALE; HUMAN; IMMUNOTOXICITY; INHALATION; LIVER TOXICITY; LONG TERM EXPOSURE; MALE; METABOLITE; MODEL; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 0033947281     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2323     Document Type: Article

References (113)

1. ATSDR. ATSDR Toxicological Profile for Trichloroethylene (update). Atlanta:Agency for Toxic Substances and Disease Registry, 1997.
2. Barton HA, Das S Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene. Regul Toxicol Pharmacol 24:269-285 (1996)
3. Davidson IWF, Beliles RP. Consideration of the target organ toxicity of trichloroethylene n terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev 23:493-599 (1991).
4. Gist GL, Burg JR. Trichloroethylene - a review of the literature from a health effects perspective. Toxicol Ind Health 11:253-307 (1995).
5. U.S. EPA. Health Assessment Document for Trichloroethylene, Final Report. EPA/600/8-82/006F. Washington, DC:US Environmental Protection Agency, 1985.
6. Barton HA, Andersen ME, Clewell HJ III. Harmonization: developing consistent guidelines for applying mode of acticn and dosimetry information to cancer and noncancer risk assessment. Hum Ecol Risk Assess 4:75-115 (1998).
7. U.S. EPA. Proposed Guidelines for Carcinogen Risk Assessment. EPA 600-P-92-003C. Washington, DC:U.S. Environmental Protection Agency, 1996.
8. U. S. EPA. Guidelines for Developmental Toxicity Risk Assessment Fed Reg 56:63798-63826 (1991).
9. U. S. EPA. Guidelines for Reproductive Toxicity Risk Assessment. EPA/630/R-96/009. Washington, DC: Office of Research and Development, 1996
10. U. S EPA. Guidelines for Neurotoxicity Risk Assessment. Fed Reg 63:26925-26954 (1998).
11. U. S. EPA. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F. Washington, DC: U. S. Environmental Protection Agency, 1994.
12. Dourson ML. Methods for Establishing Oral Reference Doses. In: Risk Assessment of Essential Elements (Mertz W, Abernathy CO, Olin SS, eds). Washington, DC:ILSI Press, 1994;51-61.
13. Dourson ML, Stara JF. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol 3:224-238 (1983).
14. Renwick AG. Data-derived safety factors for evaluation of food additives and environmental contaminants. Food Addit Contam 10-275-305 (1993).
15. Crump KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol 4:854-871 (1984).
16. Crumo KS. Calculation of benchmark doses from continuous data. Risk Anal 15:79-89 (1995).
17. Barnes DG, Daston GP, Evans JS, Jarabek AM, Kavlock RJ, Kimmel CA, Park C, Spitzet HL. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul Toxico Pharmacol 21:296-306 (1995).
18. U. S. EPA. The Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/R-94/007. Washington. DC.US Environmental Protection Agency, 1995.
19. Clewell HJ III, Gentry R, Gearhart JM. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment. J Toxicol Environ Health 52:475-515 (1997).
20. Clewell HJ III, Gentry, PR, Barton HA, Shipp AM, Yager JW, Andersen ME. Requirements for a biologically realistic cancer risk assessment for norganic arsenic Int J Tox col 18:1-17 (1999).
21. Barton HA, Clewell HJ III. Noncancer Effects Due to Trichloroethylene: Pharmacokinetics and Risk Assessment. AL-OE-BR-TR-1998-0029. Brooks AFB, TX:USAF Armstrong Laboratory, 1998.
22. NCI Carcinogenesis Bioassay of Trichloroethylene. PB-254 122. Washington, DC:National Cancer Institute. 1976.
23. NTP. Technical Report on the Carcinogenesis Bioassay of Trichloroethylene in F344/N Rats and B6C3F1/N Mice NIH Pub, No, 82-1799 Research Triangle Park, NC:National Toxicology Program, 1983
24. NTP. Toxicology and Carcinogenesis Studies of Trichloroethylene (Cas No. 79-01-6) in Four Strains of Rats [AC], August, Marshall, Osborne-Mendel) (Gavage studies). PB88-218896 Research Triangle Park, NC:National Toxicology Program, 1988.
25. Tucker AN, Sanders VM, Barnes DW, Bradshaw TJ, White KL Jr. Sain LE, Borzelleca JF, Munson AE. Toxicology of trichloroethylene in the mouse. Toxicol Appl Pharmacol 62:351-357 (1982).
26. Sanders VM. Tucker AN, White KL Jr, Kauffmann BM, Hallett P. Carchman RA, Borzelleca JF, Munson AE. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol Appl Pharmacol 62:358-368 (1982).
27. Feldman RG, Chirico-Post J, Proctor SP. Blink reflex latency after exposure to trichloroethylene in well water Arch Environ Health 43:143-148 (1988)
28. Kilburn KH, Warshaw RH Effects on neurobehavioral performance of chron c exposure to chemically contaminated well water. Toxicol Ind Health 9:391-404 (1993).
29. Henschler D, Elsasser H, Romen W, Eder E. Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, n mice. J Cancer Res Clin Oncol 107:149-156 (1984)
30. Barret L, Torch S, Leray L, Sarlieve L, Saxod R Morphometric and biochemical studies in trigeminal nerve of rat after trichloroethylene or dichloroacetylene oral administration. Neurotoxicology 13:601-614 (1992).
31. Narotsky MG, Kavlock RJ. A multid sciplinary approach to toxicological screening. II: Developmental toxicity J Toxicol Environ Health 45 145-171 (1995).
32. Moser VC, Cheek BM, MacPhai RC A multidisciplinary approach to toxicological screening III. Neurobehavioral toxicity. J Toxicol Environ Health 45:173-210 (1995).
33. NTP. Trichloroethylene: Reproducticn and Fertility Assessment in F344 Rats When Administered in Feed. Final Report PB86-190782. Research Triangle Park, NC:National Toxicology Program, 1986.
34. Taylor DH, Lagory KE, Zaccaro DJ, Pfohi RJ, Laurie RD. Effect of trichloroethylene on the exploratory and locomotor activity of rats exposed during development Sci Total Environ 47:415-420 (1985).
35. Isaacson LG, Spohler SA, Taylor DH. Trichloroethylene affects learning and decreases myelin n the rat hippocampus. Neurotoxicol Teratol 12:375-381 (1990).
36. Fredriksson A, Danielsson BR, Eriksson F. Altered behaviour in adult mice orally exposed to tri- and tetrachloroethylene as neorates Toxicol Lett 66:13-19 (1993).
37. Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ. Risk assessment in immunotoxicology. I: Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200-210 (1992).
38. Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P Kouchi Y, Craig W, et al Risk assessment in immunotoxicology II: Relationships between immune and host resistance tests Fundam Appl Toxicol 21:71-82 (1993).
39. Kauffmann BM, White KL Jr, Sanders VM, Douglas KA, Sain LE Borzelleca JF, Munson AE. Humoral and cell-mediated immune status in mice exposed to chloral hydrate Environ Health Perspect 44:147-151 (1982)
40. NTP. Trichloroethylene Reproduction and Fertility Assessment in CD-1 Mice When Administered in the Feed PB86-173150. Research Triangle Park, NC:National Toxicology Program, 1985.
41. Cosby NC, Dukelow WR. Toxicology of maternally ingested trichloroethylene (TCE) or embryoral and fetal development in mice and of TCE metabolites on in vitro fertilization. Fundam Appl Toxicol 19:268-274 (1992).
42. Dawson BV, Johnson PD, Goldberg SJ, Ulreich JB. Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water. J Am Coll Cardiol 21:1466-1472 (1993).
43. Zenick H, Blackburn K, Hope E, Richdale N, Smith MK. effects of trichloroethylene exposure on male reproductive function in rats. Toxicology 31 237-250 (1984).
44. Manson JM, Murphy M, Richdale N, Smith MK. effects of oral exposure to trichloroethylene on female reproductive function. Toxicology 32:229-242 (1984).
45. Narotsky MG, Weller EA, Chinchilli VM, Kaviock RJ. Nonadditive developmental toxicity in mixtures of trichloroethylene, di(2-ethylhexyl) phthalate, and heptachlor in a 5 × 5 × 5 design. Fundam Appl Toxicol 27:203-216 (1995).
46. Smith MK, Randall JL, Read EJ, Stober JA Teratogenic activity of trichloroacetic acid in the rat. Teratology 40:445-451 (1989).
47. Epstein DL, Nolen GA, Randall JL, Christ SA, Read EJ, Stober JA, Smith MK. Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat. Teratology 46:225-235 (1992).
48. Smith MK, Randall JL, Read EJ, Stober JA. Developmental toxicity of dichloroacetate in the rat. Teratology 46:217-223 (1992).
49. Johnson PD, Dawson BV, Goldberg SJ Cardiac teratogen city of trichloroethylene metabolites. J Am Coll Cardiol 32:540-545 (1998).
50. Johnson PD, Dawson BV, Goldberg SJ A review: trichloroethylene metabolites: potential cardiac teratocens. Environ Health Perspect 106:995-999 (1998)
51. Lagakos SW, Wessen BJ, Zelen M. An analysis of contaminated well water and health effects in Woburn, Massachusetts J Am Stat Assoc 81:583-614 (1986)
52. Maltoni C, Lefemine G, Cotti G, eds. Experimental Research on Trichloroethylene Carcinogenesis. Archives of Research on Industrial Carcinogenesis, Vol 5 (Ma toni C, Mehlman MA, eds) Princeton, NJ:Princeton Scientific Publishing, 1986.
53. Berman E, Schlicht M, Moser V, MacPhail F A multidisciplinary approach to texicological screening. I: Systemic toxicity J Toxicol Environ Health 45:127-143 (1995).
54. Stott WT, Quast JF, Watanase PG. The phamacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicol Appl Pharmacol 62:137-151 (1982).
55. Borzelleca JF, O'Hara TM, Gennings C, Granger RH, Sheppard MA, Condie LW Jr Interactions of water contaminants. I Plasma enzyme activity and response surface methodology following gavage administration of CC14 and CHC13 or TCE singly and in combination in the rat. Fundam Appl Toxicol 14:477-490 (1990).
56. Buben JA, O'Flaherty EJ. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene a dose-effect study. Toxicol Appl Pharmacol 78:105-122 (1985).
57. Elcombe CR. Species differences m carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol Suppl 8:6-17 (1985).
58. Elcombe CR, Rose MS, Pratt IS, Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene possible relevance to species differences in hepatocarcinogen city. Toxicol App Pharmacol 79 365-376 (1985).
59. Goel SK, Rao GS, Pandya KP, Shanker R. Trichloroethylene toxicity in mice a biochemical, hematological end pathological assessment. Indian J Exp Biol 30:402-406 (1992).
60. Melnick RL Jameson CW, Goehl TJ, Maronpot RR, Collins BJ, Greenwell A, Harrington FW, Wilson RE, Tomaszewski KE, Agarwal DK. Application of microencapsulation for toxicology studies. II: Toxicity of microencapsulated trichloroethylene in Fischer 344 rats. Fundam Appl Toxicol 8:432-442 (1987).
61. Merrick BA, Robinson M, Condie LW. Differing hepatoloxicity and lethality after subacute trichloroethylene exposure in aqueous or corn oil gavage vehicles in B6C3F1 Mice. J Appl Toxicol 9:15-21 (1989).
62. Maltoni C, Lefemine G, Cotti G, Perino G. Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice Ann NY Acad Sci 534:316-342 (1988)
63. Annau Z. The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol 3:417-424 (1981).
64. Haglid KG, Briving C, Hansson HA, Rosengren L, Kjellstrand P, Stavron D, Swedin U Wronski A Trichloroethylene: long-lasting changes in the brain after rehabilitation. Neurotoxicology 2:659-673 (1981).
65. Kjellstrand P, Edstrom A, Bjerkemo M, Holmquist B. Effects of trichloroethylene inhalation on acid phosphatase in rodent brain. Toxicol Lett 10 1-5 (1982).
66. Kjellstrand P, Kanje M, Bjerkemo M. regeneration of the sciatic nerve in mice and rats exposed to trichloroethylene Toxicol Lett 38:187-191 (1987)
67. Kulig BM. The effects of chronic trichloroethylene exposure on neurobehavioral functioning in the rat. Neurotoxicol Teratol 9:171-178 (1987).
68. Savolainen H, Pfaffli P, Tengen M, Vainio H. Trichloroethylene and 1,1,1-trichloroethane: effects or brain and liver after five days intermittent inhalation Arch Toxicol 38:229-237 (1977).
69. Westergren I, Kjellstrand P, Linder LE, Johansson BB. Reduction of brain specific gravity in mice prenatally exposed to trichloroethylene. Toxicol Lett 23:223-226 (1984)
70. Goldberg ME, Johnson HE, Pozzani UC, Smyth HFJ. Behavioural response of rats during inhalation of trichloroethylene and carbon disulphide vapours. Acta Pharmacol Toxicol 21:36-44 (1964).
71. Kishi R, Harabuchi I, Ikeda T, Katakura Y, Miyake H. Acute effects of trichloroethylene on blood concentrations and performance decrements in rats and their relevance to humans. Br J Ind Med 50:470-480 (1993).
72. Silverman AP, Williams H. Behaviour of rats exposed to trichloroethylene vapour. Br J Ind Med 32 308-315 (1975).
73. Blain L, Lachapelle P, Molotchnikoff S. Electroretinal responses are modified by chronic exposure to trich oroethylene. Neurotoxicology 15:627-631 (1994).
74. Boyes W, Bushnell P, Crofton K, Evans M, Sinmons J. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario Environ Health Perspect 108(suppl 2): 317-322 (2000).
75. Arito H, Takahashi M, Ishikawa T. Effect of subchronic inhalation exposure to low-level trichloroethylene on heart rate and wakefulness-sleep in freely moving rats Jpn J Ind health 36:1-8 (1994).
76. Spinas R, Stewart PA, Lee JS, Mararo DE, Forbes CD. Grauman DJ, Pettigrew HM, Blair A, Hoover RN, Cohen JL. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I Epidemiological results. Br J Ind Med 48 515-530 (1991).
77. Aranyi C, O'Shea WJ, Graham JA, Miller FJ. The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam Appl Toxicol 6:713-720 (1986)
78. Hobara T, Kobayash H, Higashihara E, Kawamoto T, Sakai T. Acute effects of 1,1,1-trichloroethane, trichloroethylene and toluene on the hematologic parameters in dogs Arch Environ Contam Toxicol 13:589-593 (1984)
79. Park PA, Gilmour MI, Selgrade MK. Pulmonary defenses to streptococcal infection following acute exposure to trichloroethylene (TCE) or chloroform (CHC13) Toxicologist 13:107 (1993)
80. Windham GC, Shusterman D, Swan SH, Fenster L, Eskenazi B. Exposure to organic solvents and adverse pregnancy outcome. Am J Ind Med 20:241-259 (1991).
81. Tola S, Vilhunen R, Jarvinen E, Korkala WL. A cohort study on workers exposed to trichloroethylene J Occup Med 22 737-740 (1980).
82. Corbett TH. Birth defects among children of nurse-anaes thetists. Anesthesiology 41:341-344 (1974).
83. Healy TE, Poole TR, Hopper A Rat fetal development and maternal exposure to trichloroethylene 100 ppm. Br J Anaesth 54:337-341 (1982).
84. Dorfmueller MA, Henne SP, York RG, Bornschein RL, Manson JM. Evaluation of teratogenicity and behavioral toxicity with inhalation exposure of maternal rats to trichloroethylene. Toxicology 14:153-166 (1979).
85. Hardin BD, Bond GP, Sikov MR, Andrew FD, Beliles RP, Niemeier RW. Testing of selected workplace chemicals for teratogenic potential. Scand J Work Environ Health 7 66-75 (1981)
86. Schwetz BA, Leony KJ, Gehring PJ. The effect of maternally inhaled trichloroethylene, perchloroethylene, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats Toxicol Appl Pharmacol 32:84-96 (1975)
87. Prendergast JA, Jones RA, Jenkins LJ Jr, Siegel J. Effects on Experimental animals of long-term inhalation of trichloroethylene, carbon tetrachloride, 1,1,1-trichloroethane, dichlorodifluoromethane, and 1,1-dichloroethylene. Toxicol Appl Pharmacol 10:270-289 (1967).
88. Odum J, Foster JR, Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem-Biol Interact 83:135-153 (1992).
89. Kimmerle G, Eben A. Metabolism, Excretion and toxicology of trichloroethylene after inhalation. 1: Experimental exposure or rats. Arch Toxikol 30:115-126 (1973).
90. Kjellstrand P, Kanje M, Mansson L, Bjerkemo M, Mortensen I, Lanke J, Holmquist B. Trichloroethylene: effects on body and organ weights in mice, rats and gerbils. Toxicology 21:105-115 (1981).
91. Kjellstrand P, Holmquist B, Alm P, Kanje M, Romare S, Jonsson I, Mansson L, Bjerkemo M. Trichloroethylene: further studies of the effects on body and organ weights and plasma butyrylclolinesterase activity in mice. Acta Pharmacol Toxicol 53:375-384 (1983).
92. Kjellstrand P, Holmquist B, Mandahl N, Bjerkemo M. Effects of continuous trichloroethylene inhalation on different strains of mice. Acta Pharmacol Toxicol 53:363-374 (1983).
93. Nakajima T, Okino T, Okuyama S, Kaneko T, Yonekura I, Sato A. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. Toxicol Appl Pharmacol 94:227-237 (1988).
94. Okino T, Nakajima T, Nakano M. Morphological and biochemical analyses of trichloroethylene hepatotoxicity: differences in ethanol- and phenobarbital-pretreated rats. Toxicol Appl Pharmacol 108:379-389 (1991).
95. Barton H, Flemming C, Lipscomb J. Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology 111:271-287 (1996).
96. Clewell H, Gentry P, Gearhart J, Allen B, Andersen M. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. Chemosphere 31:2561-2578 (1995).
97. Clewell HJ III, Andersen ME. Applying mode of action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol (in press).
98. Kodell RL, West RW. Upper confidence limits on excess risk for quantitative response. Risk Anal 13:177-182 (1993).
99. Allen BC, Kavlock RJ, Kimmel CA, Faustman EM. Dose-response assessment for developmental toxicity. III: Statistical models. Fundam Appl Toxicol 23:496-509 (1994).
100. Cresteil T. Onset of xenobiotic metabolism in children: toxicological implications. Food Addit Contam 15:45-51 (1998).
101. DeAngelo AB, Daniel FB, McMillan L, Wernsing P, Savage RE Jr. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol Appl Pharmacol 101:285-298 (1989).
102. Sanchez IM, Bull RJ. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology 64:33-46 (1990).
103. Larson JL, Bull RJ. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol 115:278-285 (1992).
104. Larson JL, Bull RJ. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115:268-277 (1992).
105. Styles JA, Wyatt I, Coutts C. Trichloroacetic acid: studies on uptake and effects on hepatic dna and liver growth in mouse. Carcinogenesis 12:1715-1719 (1991).
106. Ketcha MM, Stevens DK, Warren DA, Bishop CT, Brashear WT. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J Anal Toxicol 20:236-241 (1996).
107. Goeptar AR, Commandeur JNM, van Ommen B, van Bladeren PJ, Vermeulen NPE. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity, relevance of the mercapturic acid pathway. Chem Res Toxicol 8:3-21 (1995).
108. Breimer DD. Clinical pharmacokinetics of hypnotics. Clin Pharmacokinet 2:93-109 (1977).
109. Stewart RD, Dodd HC, Gay HH, Erley DS. Experimental human exposure to trichloroethylene. Arch Environ Health 20:64-71 (1970).
110. Nomiyama K, Nomiyama H. Dose-response relationship for trichloroethylene in man. Int Arch Occup Environ Health 39:237-248 (1977).
111. Windemuller FJ, Ettema JH. Effects of combined exposure to trichloroethylene and alcohol on mental capacity. Int Arch Occup Environ Health 41 77-85 (1978).
112. Salvini M, Binaschi S, Riva M. Evaluation of the psychophysiological functions in humans exposed to trichloroethylene. Br J Ind Med 28:293-295 (1971).
113. Konietzko H, Elster I, Bencsath A, Drysch K, Weichardt H. EEE-Veranderungen unter Definierter Trichlorathylen-Exposition Int Arch Occup Environ Health 35:257-264 (1975).